Recently, it has been observed that reactions between NO-derived species, unsaturated fatty acids, and lipid oxidation intermediates yield fatty acid oxidation and nitration products (2, 3). Nitroalkene derivatives of all principal unsaturated fatty acids are present in human blood and urine and represent an abundant pool of bioactive oxides of nitrogen, with tissue levels of these species influenced by endogenous redox reactions and dietary intake of nitrated lipids. Nitrolinoleic acid (10-and 12-nitro-9,12-octadecadienoic acid, LNO 2 ) is present in plasma and red blood cell membranes at concentrations of Ϸ500 nM (3). Nitroalkene fatty acid derivatives induce adaptive antiinflammatory responses by means of induction of cGMPdependent and cGMP-independent cell signaling reactions that result in inhibition of platelet and neutrophil activation (4, 5), vessel relaxation (6), and activation of peroxisome proliferatoractivated receptor (PPAR)-dependent gene expression (7).
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Vascular tissues maintain viability during inflammation by eliciting adaptive and protective responses. Recent studies have shown that heme oxygenase 1 (HO-1) plays a central role in vascular inflammatory signaling reactions and mediates a protective response in several inflammatory diseases, including atherosclerosis, acute renal failure, vascular restenosis, transplant rejection, and sepsis (reviewed in ref. 8) . HO-1, a 32-kDa enzyme, is the ratelimiting step in the degradation of heme, yielding biliverdin, carbon monoxide, and iron (9) . Biliverdin is subsequently converted to bilirubin by biliverdin reductase. All heme catabolites can contribute to integrative protective responses to oxidative stress (10) . Specifically, HO activity reduces levels of prooxidative heme (11) , with the iron released from heme catabolism rendered largely redox-inactive by ferritin sequestration. Ferritin is often coinduced with HO-1 and also displays cytoprotective functions (12) . Heme degradation serves as the major endogenous source of carbon monoxide, a gas isoelectronic with NO that displays antiinflammatory, antiapoptotic, vasodilatory, and immune modulatory functions (13) (14) (15) . The porphyrin metabolites biliverdin and bilirubin also scavenge reactive oxygen species (16, 17) . Finally, HO-1 induction is associated with concomitant up-regulation of the cell-cycle regulatory protein p21, which mediates antiapoptotic signaling during oxidative injury (18) . Biliverdin, bilirubin, and carbon monoxide, acting individually or in concert, exert protective effects in vitro and in vivo in animal models of inflammatory injury (19) .
Because both nitroalkenes and HO-1 are emerging as key mediators of adaptive inflammatory responses, the impact of LNO 2 on HO-1 gene expression was examined. Herein, the marked up-regulation of HO-1 gene expression by LNO 2 in vascular cells is reported, with this induction occurring primarily at the transcriptional level. We conclude that LNO 2 mediates the induction of HO-1 by means of PPAR␥-independent and both NO-dependent and NO-independent mechanisms. and 15-fold 16 h after addition of 1, 5, and 10 M LNO 2 , respectively (Fig. 1B) . Induction of HO-1 was specifically due to the nitroalkene moiety of LNO 2 , because linoleic acid (LA) did not induce HO-1 expression (Fig. 1 A-C) . Maximum induction of HO-1 mRNA occurred at 4 h with 10 M LNO 2 , with a corresponding increase in maximal protein expression at 12 h ( Fig. 1 C and D) .
For endothelial cells, 13(S)-hydroperoxy-octadecadienoic acid (13-HPODE) is the most potent HO-1-inducing component of oxidized low-density lipoprotein (20) . Cells treated with equimolar amounts of LNO 2 , hemin, and 13-HPODE revealed that LNO 2 -dependent HO-1 induction far surpassed that induced by 13-HPODE and rivaled that of hemin (Fig. 1E) . Similar extents of HO-1 mRNA expression in response to these mediators also occurred (data not shown). Oxidized lipids, including 13-HPODE, induce HO-1 expression in HAEC by means of irondependent, deferoxamine (DFO)-inhibitable mechanisms (21, 22) . HAEC pretreated with 5, 50, or 500 M DFO for 16 h and then exposed to 5 M LNO 2 in the presence of DFO showed no impact of DFO toward LNO 2 
HO-1 Induction by LNO2 Occurs by NO-Dependent and NO-Independent
Mechanisms. NO induces HO-1 gene expression in a variety of cell types (24) (25) (26) . Because LNO 2 decays to release NO in aqueous milieu (27) , the contribution of NO to HO-1 induction was explored. HAEC were pretreated with the NO scavenger 2-(4-carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (cPTIO; 8, 80, and 800 M) for 30 min, followed by treatment
-diolate (SNONOate; 500 M) was used as a positive control for NO-mediated induction of HO-1. cPTIO (800 M) completely reversed SNONOate induction of HO-1 mRNA, as expected (Fig. 3A) . However, treatment of cells with cPTIO in the presence of LNO 2 only partially reversed HO-1 transcript levels when compared with induction of HO-1 by LNO 2 alone (Fig. 3 A and B) . The effect of another NO scavenger, oxymyoglobin (1, 10, and 100 M), was also examined. As shown in Fig. 3C , pretreatment with oxymyoglobin at concentrations of 10 and 100 M induced only a modest (Ϸ25%) decrease in LNO 2 -mediated HO-1 induction. These results support that LNO 2 -induced HO-1 expression occurs by both NO-dependent and NO-independent mechanisms. This finding was further corroborated by the effects of SNONOate and LNO 2 on promoter constructs transfected into HAEC (Fig. 3D) . LNO 2 robustly activated a Ϫ4.5-kb human HO-1 promoter construct, whereas the NO donor did not significantly activate this construct. These results affirm that LNO 2 -mediated HO-1 gene expression is predominantly NO-independent. LNO 2 reacts with water when solvated in neutral aqueous milieu to yield nitrohydroxy derivatives (27) . To evaluate whether this or other LNO 2 decay products influence HO-1 gene expression, 50 M LNO 2 was first added to 100 mM KPi͞100 M diethylenetriaminepentaacetate (pH 7.4) for 24 h. HAEC were then treated with decay products from 5 M LNO 2 in culture medium for 4 h. HO-1 message in samples treated with decayed LNO 2 at 24 h was decreased (Ϸ45%) when compared with cells treated with native LNO 2 (Fig. 3E) . Mass spectrometric analysis of 24-h-decayed LNO 2 confirmed loss of the parent ion with Ϸ20% of residual LNO 2 remaining in the samples (Fig. 3F) .
LNO2 Induces HO-1 by PPAR␥-Independent Mechanisms. LNO 2 is a potent endogenous ligand for PPAR␥ and, to a lesser extent, PPAR␣ and PPAR␦ (7). Previously it was proposed that PPAR␥ agonists like 15-deoxy-⌬ 12,14 -prostaglandin J 2 contribute to induction of HO-1 gene expression (28) . To explore whether LNO 2 -mediated HO-1 induction is PPAR␥-dependent, the presence of PPAR␥ receptors in HAEC was first confirmed by immunoblot analysis (Fig. 4A) , and then HAEC were treated with the PPAR␥ receptor antagonist GW9662 (5, 10, and 20 M) and LNO 2 (5 M). GW9662 had no effect on LNO 2 -mediated HO-1 mRNA and protein expression and, in contrast, modestly enhanced HO-1 mRNA induction (Fig. 4 A and B) . A methyl derivative of LNO 2 (Me-LNO 2 ), competent to release NO and retaining electrophilic reactivity but lacking a capacity to interact with critical motifs responsible for high-affinity PPAR␥ ligand binding (unpublished observations), induced HO-1 mRNA expression to a similar degree as LNO 2 , further supporting that endothelial LNO 2 -mediated HO-1 gene expression is PPAR␥-independent (Fig. 4C) . Fig. 5 A and B) . The induction was dose-dependent, and native LA alone did not induce HO-1 (Fig. 5B) . Immunofluorescence microscopy revealed that HO-1 induction was localized to aortic endothelial and smooth muscle cells (Fig. 5C) .
HO-1 protein expression at 12 and 16 h, exceeding levels of HO-1 expression induced by equimolar concentrations of 13-HPODE (

Discussion
There is an expanding appreciation that NO-derived species direct the oxidation, nitrosation, and nitration of diverse biomolecules, yielding products with altered structural and functional properties (29) . In the context of cell signaling, NO-derived species regulate protein kinase and phosphatase activities, structural protein function, redox-sensitive transcription factors, mitochondrial respiratory and apoptotic function, and, in general, net cellular redox status (30) . Recently we observed that NO-dependent oxidative inflammatory reactions yield fatty acid nitration products that display cell signaling capabilities (2, 4) . These fatty acid nitroalkene derivatives, the most clinically abundant bioactive oxides of nitrogen, are unique in that they exhibit pluripotent cell signaling properties (31) . These species act in part by serving as hydrophobically regulated NO donors and potent endogenous PPAR ligands (7, 27) . The chemical properties of nitroalkenes that facilitate their unique cell signaling actions include (i) the strong electrophilic nature of the ␤ carbon adjacent to the alkenyl nitro bond, (ii) an ability to readily undergo Nef-like acid-base reactions to release NO, (iii) their ability to partition into both hydrophobic and hydrophilic compartments, and (iv) a strong affinity for the PPAR ligand binding pocket.
LNO 2 induces HO-1 mRNA and protein in HAEC by means of mechanisms distinct from those of oxidized LA (Fig. 3D) . This induction of HO-1 was regulated primarily at the transcriptional level and does not involve mRNA stabilization (Fig. 2) . Promoter studies showed that HO-1 induction requires sequences distinct from those required for NO donor-and oxidized lipid-mediated induction (Fig. 3D) . LNO 2 also induces HO-1 expression in a PPAR␥-independent fashion in endothelial cells (Fig. 4) . To our knowledge, these data are the first to demonstrate that fatty acid nitroalkene derivatives activate the gene expression of a critical cell inflammatory signaling and oxidative defense enzyme, HO-1.
Proinflammatory stimuli, including oxidized low-density lipoprotein, cytokines, and NO induce HO-1 gene expression (20, 21, (23) (24) (25) (26) . Of note, the mechanism of HO-1 induction by LNO 2 appears to be distinct from these other stimuli and may also account for some component of the HO-1-inducing actions of these stimuli, in as much as these stimuli can include or induce fatty acid nitration products. This finding is corroborated by data showing (i) marked induction of HO-1 by LNO 2 to an extent that far exceeds that induced by equimolar concentrations of oxidized lipid derivatives (Fig. 1E) , (ii) induction of HO-1 that occurs even in the presence of the NO scavengers cPTIO and oxymyoglobin (Fig. 3 A-C) , (iii) persistence of HO-1 induction by LNO 2 after decay and release of NO by the parent molecule (Fig. 3E) , (iv) differential responses of the Ϫ4.5-kb human HO-1 promoter to LNO 2 compared with 13-HPODE (Fig. 3D) , and (v) differential activation of the HO-1 promoter by LNO 2 and the NO donor SNONOate (Fig. 3D) . These data support that HO-1 induction by LNO 2 occurs by predominantly NO-independent mechanisms and support the presence of different transcriptional response elements for nitrated versus oxidized LA. The observation that LNO 2 -mediated HO-1 induction is only partially NO-dependent is provocative, because the aqueous decay of LNO 2 yields NO, an alternative stimulus for HO-1 induction.
Fatty acids such as 13-HPODE, lysophosphatidic acid, and 15-deoxy-⌬ 12,14 -prostaglandin J 2 are weak ligands for the nuclear hormone receptor PPAR␥ that do not act within physiological concentration ranges (7, 32) . 15-Deoxy-⌬ 12,14 -prostaglandin J 2 is reported to induce HO-1 in several cell types by mainly PPAR␥-independent mechanisms (28, 33) . LNO 2 is a robust PPAR␥ ligand that acts at physiological concentrations and rivals thiazolidinedione PPAR␥ agonists for potency in activating PPAR␥-driven reporter gene expression, macrophage CD-36 expression, adipocyte differentiation, and glucose uptake (7). Herein LNO 2 induced full HO-1 expression even in the presence of the PPAR␥ receptor antagonist GW9662. The non-PPAR␥-activating methyl derivative of LNO 2 also retains HO-1 inducibility, supporting a PPAR␥-independent pathway for LNO 2 -mediated HO-1 induction in endothelial cells. Furthermore, the Ϫ11.6-kb human HO-1 promoter does not contain any consensus PPAR␥ response elements (AG-GTCA n AGGTCA) (search performed using VECTOR NTI software, Invitrogen) that would be expected in promoters of PPARdependent target genes. Further studies to delineate the specific LNO 2 -responsive element in the human HO-1 promoter, as well as the upstream signaling pathways that mediate HO-1 gene expression by LNO 2 , remain of interest.
Activation of HO-1 by LNO 2 has relevance to inflammatory injury, specifically with respect to vascular disorders. In this regard, several recent studies have shown that expression of HO-1 beneficially limits atherosclerosis and vascular restenosis (34, 35) . Plasma concentrations of free LNO 2 in normal healthy humans is Ϸ500 nM (3), and in this study concentrations of LNO 2 as low as 1 M were associated with HO-1 induction. Increased levels of 18:2 nitration products (nitrolinoleate and cholesteryl nitrolinoleate) are present in plasma from hyperlipidemic patients compared with normolipidemic patients (36, 37) . Using stable isotope dilution LC-mass spectrometry, current data indicate significantly increased levels of nitroalkenes in a variety of inflammatory conditions and animal models of inflammation (unpublished observations). This increased extent of fatty acid nitration is not unexpected, because the NOdependent redox reactions induced by inflammatory stimuli are a byproduct of both the increased expression and uncoupled electron transfer activity of NO synthases and increased rates of production of reactive oxygen species by a variety of cellular oxidases and oxygenases. One consequence of this convergence of reactive species is an increase in rates of formation of various lipid radical intermediates and oxides of nitrogen (e.g., peroxynitrite and nitrogen dioxide) that support nitration of unsaturated fatty acids (2) .
In summary, we show that LNO 2 is a potent inducer of HO-1 gene expression, a central defensive enzyme in tissue antiinflammatory responses to vascular injury. At present, nitroalkenes are appreciated to mediate multiple adaptive inflammatory signaling actions that influence the differentiated functions of platelets, neutrophils, macrophages, smooth muscle cells, and now endothelium (5) (6) (7) 38) . Considering the promising vascular protective effects of HO-1 expression, the present observations reveal that induction of HO-1 expression represents a key cell signaling action of inflammatory-derived lipid nitroalkene derivatives.
Methods
Reagents. Tissue culture media, serum, and supplements were from Clonetics (Walkersville, MD). Hemin, LA, Act D, cycloheximide, diethylaminoethyl-dextran, and horse heart myoglobin were from Sigma. cPTIO and spermine NONOate (SNONOate) were from EMD Biosciences (San Diego). Purified 13-HPODE, ebselen, and butylated hydroxytoluene were from Cayman Chemical (Ann Arbor, MI). Anti-HO-1 antibody (SPA-896) was from Stressgen Biotechnologies (Vancouver, Canada), anti-human PPAR␥ antibody was from Santa Cruz Biotechnology, and anti-actin antibody was from Sigma. For the preparation of oxymyoglobin, metmyoglobin was reduced by using sodium dithionite, desalted by exclusion chromatography on a Sephadex PD-10 column, and further oxygenated by equilibration with 100% oxygen as described (27) .
Synthesis of LNO2 and Methyl Ester Derivative of LNO2.
Purification and quantitation of LNO 2 was as described (3). LNO 2 was derivatized to a methyl ester (Me-LNO 2 ) by adding 1 ml of boron trifluoride͞methanol (Pierce) to 30 mol LNO 2 for 6 min at 50°C. The reaction mixture was extracted by using the Bligh and Dyer method (39) and purified by using thin layer chromatography. Me-LNO 2 concentration was calculated by chemiluminescent nitrogen detection (3).
Cell Culture. Primary cultures of HAEC (Clonetics) were passaged as described (22) in endothelial basal medium containing 10% FBS, 6 g͞ml bovine brain extract, 10 ng͞ml epidermal growth factor, 1 g͞ml hydrocortisone, 50 g͞ml gentamycin, and 50 g͞ml amphotericin B. Studies were performed on confluent monolayers of HAEC over a range of five to seven passages. All cells were grown at 37°C in 95% air and 5% CO 2 . For all induction experiments, cells were incubated in 1% FBS-containing medium. Control cells were treated with the lipid vehicle methanol at concentrations used for fatty acid derivatives (Ͻ0.1% vol͞vol).
Northern and Western Blot Analysis. RNA and protein were extracted from cultured cells and analyzed as described (20) . Purified RNA (3 g per lane) was electrophoresed, blotted onto a nylon membrane (Amersham Pharmacia), and probed for human HO-1 or GAPDH. Autoradiographs were scanned on a Hewlett-Packard Scanjet 4C by using PHOTOSHOP software (Adobe Systems, San Jose, CA), and densitometry was performed by using NIH SCION IMAGE 4.02 software (Scion, Frederick, MD). Whole-cell protein was lysed in RIPA buffer and quantitated by using a Bradford assay (Bio-Rad), and 15 g of total protein was electrophoresed on a 12% Tris-Glycine SDS͞PAGE gel. Freshly isolated rat aortic rings (1 mm) were treated with control (methanol) or 25 M LNO 2 for 2, 4, 8, 12, or 16 h and lysed by homogenization in RIPA buffer with protease inhibitors. After transfer to a polyvinylidene fluoride membrane (Millipore) HO-1 and actin were detected by using 1:5,000 dilutions of primary rabbit polyclonal antibodies followed by a horseradish peroxidase-conjugated anti-rabbit IgG. Protein was visualized by using the ECL chemiluminescent detection system (Amersham Pharmacia).
